Cargando…
Sustained complete remission of steroid- and cyclophosphamide-resistant minimal-change disease with a single course of rituximab therapy
We report a case of steroid- and cyclophosphamide-resistant nephrotic syndrome secondary to minimal-change disease occurring in an otherwise healthy 19-year-old female, responding rapidly to two doses of rituximab therapy. Complete disease remission has been sustained up to last follow-up (32 months...
Autores principales: | Janardan, Jyotsna, Ooi, Khai, Menahem, Solomon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377744/ https://www.ncbi.nlm.nih.gov/pubmed/25852892 http://dx.doi.org/10.1093/ckj/sfu022 |
Ejemplares similares
-
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
por: Cortazar, Frank B., et al.
Publicado: (2017) -
Extended infusion of rituximab combined with steroids is effective in inducing remission and reducing relapse in adult minimal change disease
por: Liu, Diankun, et al.
Publicado: (2021) -
Intravenous cyclophosphamide induces remission in children with difficult to treat steroid resistant nephrotic syndrome from minimal change disease
por: Haddad, Maha, et al.
Publicado: (2021) -
Rituximab Induces Complete Remission of Proteinuria in a Patient With Minimal Change Disease and No Detectable B Cells
por: Webendörfer, Maximilian, et al.
Publicado: (2021) -
Complete remission of coronary vasculitis in Churg–Strauss Syndrome by prednisone and cyclophosphamide
por: Riksen, Niels P., et al.
Publicado: (2010)